New Key Statistics Module, Z-Score and F-Score
NAS:LXRX Key Ratios
Market Cap $ M | 661.53 |
Enterprise Value $ M | 452.36 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.76 |
Price/Sales | 130.71 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 3.00 |
EPS (TTM) $ | -0.78 |
Beneish M-Score | 4.12 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -2.44 |
EV-to-EBITDA | -2.44 |
PEG | -- |
Shares Outstanding M | 361.49 |
Net Margin (%) | -5,550.87 |
Operating Margin % | -5,412.11 |
Pre-tax Margin (%) | -5,550.87 |
Quick Ratio | 11.49 |
Current Ratio | 11.51 |
ROA % (ttm) | -62.64 |
ROE % (ttm) | -106.62 |
ROIC % (ttm) | -314.66 |
Dividend Yield % | -- |
Altman Z-Score | -4.72 |
LXRX Number of Guru Trades
LXRX Volume of Guru Trades
Gurus Latest Trades with NAS:LXRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:LXRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Lexicon Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:LXRX
Total 0- 1